PE20080133A1 - 5-amino-6-bromo-n-{[1-(tetrahidro-2h-piran-4-ilmetil)-4-piperidinil]metil}-3,4-dihidro-2h-cromen-8-carboxamida como activador del receptor 5-ht4 - Google Patents

5-amino-6-bromo-n-{[1-(tetrahidro-2h-piran-4-ilmetil)-4-piperidinil]metil}-3,4-dihidro-2h-cromen-8-carboxamida como activador del receptor 5-ht4

Info

Publication number
PE20080133A1
PE20080133A1 PE2007000187A PE2007000187A PE20080133A1 PE 20080133 A1 PE20080133 A1 PE 20080133A1 PE 2007000187 A PE2007000187 A PE 2007000187A PE 2007000187 A PE2007000187 A PE 2007000187A PE 20080133 A1 PE20080133 A1 PE 20080133A1
Authority
PE
Peru
Prior art keywords
methyl
piperidinyl
bromo
amino
ilmetyl
Prior art date
Application number
PE2007000187A
Other languages
English (en)
Inventor
Mahmood Ahmed
Neil Derek Miller
Stephen Frederick Moss
Gareth John Sanger
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20080133A1 publication Critical patent/PE20080133A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A UN COMPUESTO DERIVADO DE BENZAMIDA: 5-AMINO-6-BROMO-N-{[1-(TETRAHIDRO-2H-PIRAN-4-ILMETIL)-4-PIPERIDINIL]METIL}-3,4-DIHIDRO-2H-CROMEN-8-CARBOXAMIDA Y SUS SALES, DE FORMULA (A). TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION, QUE COMPRENDE EN HACER REACCIONAR 5-AMINO-6-BROMO-3,4-DIHIDRO-2H-CROMEN-8-CARBOXILICO PROTEGIDO CON {[1-(TETRAHIDRO-2H-PIRANILMETIL)-4-PIPERIDINIL]METIL}-AMINA, Y OPCIONALMENTE LA DESPROTECCION Y LA FORMACION DE LA SAL CORRESPONDIENTE. DICHO COMPUESTO ES UN ACTIVADORES DEL RECEPTOR 5-HT4, POR LO QUE ES UTIL EN EL TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER, TRASTORNOS NEUROLOGICOS RELACIONADOS Y ENFERMEDADES GI FUNCIONALES
PE2007000187A 2006-02-22 2007-02-20 5-amino-6-bromo-n-{[1-(tetrahidro-2h-piran-4-ilmetil)-4-piperidinil]metil}-3,4-dihidro-2h-cromen-8-carboxamida como activador del receptor 5-ht4 PE20080133A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0603550.5A GB0603550D0 (en) 2006-02-22 2006-02-22 Novel compounds

Publications (1)

Publication Number Publication Date
PE20080133A1 true PE20080133A1 (es) 2008-04-24

Family

ID=36178554

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000187A PE20080133A1 (es) 2006-02-22 2007-02-20 5-amino-6-bromo-n-{[1-(tetrahidro-2h-piran-4-ilmetil)-4-piperidinil]metil}-3,4-dihidro-2h-cromen-8-carboxamida como activador del receptor 5-ht4

Country Status (6)

Country Link
US (1) US20070232657A1 (es)
AR (1) AR059864A1 (es)
GB (1) GB0603550D0 (es)
PE (1) PE20080133A1 (es)
TW (1) TW200808779A (es)
WO (1) WO2007096352A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100053626A (ko) * 2007-08-15 2010-05-20 메모리 파마슈티칼스 코포레이션 5-ｈｔ6 수용체 친화성을 나타내는 3'-치환된 화합물
AR080055A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de pirazolo-[5,1-b]-oxazol como antagonistas de los receptores de crf -1
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
EP2531490B1 (en) 2010-02-02 2014-10-15 Novartis AG Cyclohexyl amide derivatives as crf receptor antagonists
WO2011099305A1 (en) * 2010-02-12 2011-08-18 Raqualia Pharma Inc. 5-ht4 receptor agonists for the treatment of dementia
EP2724723A1 (en) * 2012-10-25 2014-04-30 Universitätsklinikum Hamburg-Eppendorf Tegaserod for use in the treatment of nerve injuries
JP6295247B2 (ja) * 2013-03-25 2018-03-14 ゼリア新薬工業株式会社 食後期の胃運動亢進剤
ES2734734T3 (es) * 2015-02-13 2019-12-11 Suven Life Sciences Ltd Compuestos de amida como agonistas del receptor 5-HT4

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW402591B (en) * 1997-07-11 2000-08-21 Janssen Pharmaceutica Nv Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
JP2006502180A (ja) * 2002-09-20 2006-01-19 ファイザー株式会社 ５−ｈｔ４レセプターモジュレーターとしてのｎ−置換されたピペリジニル−イミダゾピリジン化合物
WO2005092882A1 (en) * 2004-03-01 2005-10-06 Pfizer Japan, Inc. 4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders

Also Published As

Publication number Publication date
US20070232657A1 (en) 2007-10-04
WO2007096352A1 (en) 2007-08-30
TW200808779A (en) 2008-02-16
GB0603550D0 (en) 2006-04-05
AR059864A1 (es) 2008-05-07

Similar Documents

Publication Publication Date Title
PE20080133A1 (es) 5-amino-6-bromo-n-{[1-(tetrahidro-2h-piran-4-ilmetil)-4-piperidinil]metil}-3,4-dihidro-2h-cromen-8-carboxamida como activador del receptor 5-ht4
BR122019017036B8 (pt) compostos de arilamidas substituídas por tetrazol, usos dos referidos compostos e composição farmacêutica
EA201070164A1 (ru) Твердый препарат, включающий алоглиптин и гидрохлорид метформина
CY1112429T1 (el) Υποκατεστημενα παραγωγα σουλφοναμιδιου
CY1117726T1 (el) Θετικοι αλλοστερικοι ρυθμιστες υποδοχεα μ1 κινολιναμιδιου
EA201290078A1 (ru) Гетероциклические соединения для ингибирования pask
ATE482210T1 (de) Oxadiazolderivate als s1p1-rezeptor-agonisten
CY1111170T1 (el) Ενωσεις διαρυλ αιθερα ουριας
CR10948A (es) Compuestos triciclicos, composiciones y procedimientos
BR112012018386A8 (pt) "inibidores isoindolinona de fosfatidilinositol 3-quinase"
MX2011013034A (es) 1-(piperidin-4-yl)-pirazol derivados como moduladores de gpr 119.
SI2091948T1 (sl) Novi inhibitorji glutaminil ciklaze
ECSP088973A (es) Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3)
SV2008003045A (es) Aminotetrahidropiranos como inhibidores de dipertidil, peptidasa-iv para el tratamiento o prevencion de diabetes
UY30414A1 (es) Metano sulfonatos, propano-1-sulfonatos y ciclopropan sulfonatos sustituidos con [2,3,4,8-tetrahidroimidazo-[1,5-al-pirimidin-8-il]-fenilo, composiciones farmacéuticas conteniéndolos y aplicaciones.
ATE552246T1 (de) Substituierte aryloxy-n- bicyclomethylacetamidverbindungen als vr1- antagonisten
EA201170705A1 (ru) Арилметилбензохиназолиноны в качестве позитивных аллостерических модуляторов рецептора м1
CL2009000402A1 (es) Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras.
MX2013001614A (es) Compuestos heterociclico.
UA112055C2 (uk) Солі 4-[2-[[5-метил-1-(2-нафталініл)-1h-піразол-3-іл]оксі]етил]морфоліну
EA201190207A1 (ru) Соединения для лечения метаболических расстройств
UY30558A1 (es) Derivados de pirazol como agentes antiagregantes plaquetarios y antitromboticos
UY30052A1 (es) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas
MX2009003981A (es) Agentes moduladores del receptor de calcio.
UA109290C2 (uk) Спільні кристали і солі інгібіторів ccr3

Legal Events

Date Code Title Description
FD Application declared void or lapsed